Compare IPEX & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPEX | COYA |
|---|---|---|
| Founded | 2024 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.2M | 126.6M |
| IPO Year | 2025 | 2022 |
| Metric | IPEX | COYA |
|---|---|---|
| Price | $10.31 | $4.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 14.9K | ★ 322.8K |
| Earning Date | 04-15-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $3,987,706.00 |
| Revenue This Year | N/A | $70.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $41.16 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.86 | $3.94 |
| 52 Week High | $10.40 | $8.29 |
| Indicator | IPEX | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 44.92 |
| Support Level | $10.27 | $4.45 |
| Resistance Level | $10.35 | $4.86 |
| Average True Range (ATR) | 0.03 | 0.34 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 87.50 | 77.98 |
Inflection Point Acquisition Corp V is a blank check company.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.